The NCI60 human tumour cell line anticancer drug screen (Q29614975)

Europe PubMed Central

title

The NCI60 human tumour cell line anticancer drug screen (English)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16990858

30 April 2017

author name string

Shoemaker RH

series ordinal

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16990858

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16990858

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

October 2006

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16990858

30 April 2017

published in

Nature Reviews Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16990858

30 April 2017

volume

6

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16990858

30 April 2017

page(s)

813-23

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16990858

30 April 2017

issue

10

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16990858

Enhancing TRAIL-induced apoptosis by Bcl-X(L) siRNA.

30 April 2017

cites work

1 reference

Banded Marker Chromosomes as Indicators of Intraspecies Cellular Contamination

21 January 2018

1 reference

Inter- and Intraspecies Contamination of Human Breast Tumor Cell Lines HBC and BrCa5 and Other Cell Cultures

31 March 2020

1 reference

Cell lines as an investigational tool for the study of biology of small cell lung cancer

31 March 2020

1 reference

Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung

31 March 2020

1 reference

A gene expression database for the molecular pharmacology of cancer

31 March 2020

1 reference

Further evidence to support the melanocytic origin of MDA-MB-435

31 March 2020

1 reference

Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

31 March 2020

1 reference

Cell line designation change: multidrug-resistant cell line in the NCI anticancer screen

31 March 2020

1 reference

A potential role for imaging technology in anticancer efficacy evaluations

31 March 2020

1 reference

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

31 March 2020

1 reference

A semiautomated microculture method for investigating growth inhibitory effects of cytotoxic compounds on exponentially growing carcinoma cells

31 March 2020

1 reference

New colorimetric cytotoxicity assay for anticancer-drug screening

31 March 2020

1 reference

Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines

31 March 2020

1 reference

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

31 March 2020

1 reference

New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity

31 March 2020

1 reference

Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm.

31 March 2020

1 reference

Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen

31 March 2020

1 reference

Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines

31 March 2020

1 reference

Anticancer specificity of some ellipticinium salts against human brain tumors in vitro

31 March 2020

1 reference

Preclinical evaluation of 9-chloro-2-methylellipticinium acetate alone and in combination with conventional anticancer drugs for the treatment of human brain tumor xenografts.

31 March 2020

1 reference

Structurally simplified macrolactone analogues of halichondrin B.

31 March 2020

1 reference

Diazonamide A and a synthetic structural analog: disruptive effects on mitosis and cellular microtubules and analysis of their interactions with tubulin

31 March 2020

1 reference

Spirastrellolide A: revised structure, progress toward the relative configuration, and inhibition of protein phosphatase 2A

31 March 2020

1 reference

4-Hydroxybenzoyl derivative from the aqueous extract of the hydroid Campanularia sp.

31 March 2020

1 reference

Four diterpenoid inhibitors of Cdc25B phosphatase from a marine anemone

31 March 2020

1 reference

The psammaplysenes, specific inhibitors of FOXO1a nuclear export

31 March 2020

1 reference

Investigation of brominated tryptophan alkaloids from two thorectidae sponges: Thorectandra and Smenospongia

31 March 2020

1 reference

Alertenone, a dimer of suberosenone from Alertigorgia sp

31 March 2020

1 reference

Isolation and structure/activity features of halomon-related antitumor monoterpenes from the red alga Portieria hornemannii

31 March 2020

1 reference

Lobatamides A and B, Novel Cytotoxic Macrolides from the TunicateAplidium lobatum†

31 March 2020

1 reference

Salicylihalamides A and B, Novel Cytotoxic Macrolides from the Marine Sponge Haliclona sp.

31 March 2020

1 reference

Salicylihalamide A inhibits the V0 sector of the V-ATPase through a mechanism distinct from bafilomycin A1.

31 March 2020

1 reference

In vivo cultivation of tumor cells in hollow fibers

31 March 2020

1 reference

Neural computing in cancer drug development: predicting mechanism of action

31 March 2020

1 reference

Use of the Kohonen self-organizing map to study the mechanisms of action of chemotherapeutic agents.

31 March 2020

1 reference

An information-intensive approach to the molecular pharmacology of cancer.

31 March 2020

1 reference

Mining the National Cancer Institute's tumor-screening database: identification of compounds with similar cellular activities

31 March 2020

1 reference

Linking the growth inhibition response from the National Cancer Institute's anticancer screen to gene expression levels and other molecular target data

31 March 2020

1 reference

Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor

31 March 2020

1 reference

Anthrax lethal factor causes proteolytic inactivation of mitogen-activated protein kinase kinase

31 March 2020

1 reference

Anthrax lethal factor proteolysis and inactivation of MAPK kinase.

31 March 2020

1 reference

Identification of small molecule inhibitors of anthrax lethal factor

31 March 2020

1 reference

Proteasome inhibition in cancer: development of PS-341.

31 March 2020

1 reference

Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells

31 March 2020

1 reference

BRAF mutation predicts sensitivity to MEK inhibition

31 March 2020

1 reference

Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications

31 March 2020

1 reference

Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics

31 March 2020

1 reference

Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor

31 March 2020

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16990858

31 March 2020

Identifiers

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

123285

1053488336

0 references

123285

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16990858

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017